Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents

The current study presents the design, synthesis, and evaluation of novel cytochrome P450 17A1 (CYP17A1) ligands. CYP17A1 is a key enzyme in the steroidogenic pathway that produces androgens among other steroids, and it is implicated in prostate cancer. The obtained compounds are potent enzyme inhib...

Full description

Bibliographic Details
Main Authors: Tomasz M. Wróbel, Oksana Rogova, Kasper L. Andersen, Rahul Yadav, Simone Brixius-Anderko, Emily E. Scott, Lars Olsen, Flemming Steen Jørgensen, Fredrik Björkling
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/14/4868
id doaj-34dce99125be4d5fa04c03cb349df6f3
record_format Article
spelling doaj-34dce99125be4d5fa04c03cb349df6f32020-11-25T03:38:46ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-07-01214868486810.3390/ijms21144868Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer AgentsTomasz M. Wróbel0Oksana Rogova1Kasper L. Andersen2Rahul Yadav3Simone Brixius-Anderko4Emily E. Scott5Lars Olsen6Flemming Steen Jørgensen7Fredrik Björkling8Department of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, DenmarkDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, DenmarkBiotech Research and Innovation Centre (BRIC), University of Copenhagen, Ole Maaløes Vej 5, DK-2200 Copenhagen, DenmarkDepartment of Medicinal Chemistry, University of Michigan, 428 Church Street, Ann Arbor, Michigan, MI 48109-1065, USADepartment of Medicinal Chemistry, University of Michigan, 428 Church Street, Ann Arbor, Michigan, MI 48109-1065, USADepartment of Medicinal Chemistry, University of Michigan, 428 Church Street, Ann Arbor, Michigan, MI 48109-1065, USADepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, DenmarkDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, DenmarkDepartment of Drug Design and Pharmacology, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, DenmarkThe current study presents the design, synthesis, and evaluation of novel cytochrome P450 17A1 (CYP17A1) ligands. CYP17A1 is a key enzyme in the steroidogenic pathway that produces androgens among other steroids, and it is implicated in prostate cancer. The obtained compounds are potent enzyme inhibitors (sub µM) with antiproliferative activity in prostate cancer cell lines. The binding mode of these compounds is also discussed.https://www.mdpi.com/1422-0067/21/14/4868cytochrome P450 17A1, CYP17A1prostate cancerenzyme inhibition
collection DOAJ
language English
format Article
sources DOAJ
author Tomasz M. Wróbel
Oksana Rogova
Kasper L. Andersen
Rahul Yadav
Simone Brixius-Anderko
Emily E. Scott
Lars Olsen
Flemming Steen Jørgensen
Fredrik Björkling
spellingShingle Tomasz M. Wróbel
Oksana Rogova
Kasper L. Andersen
Rahul Yadav
Simone Brixius-Anderko
Emily E. Scott
Lars Olsen
Flemming Steen Jørgensen
Fredrik Björkling
Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
International Journal of Molecular Sciences
cytochrome P450 17A1, CYP17A1
prostate cancer
enzyme inhibition
author_facet Tomasz M. Wróbel
Oksana Rogova
Kasper L. Andersen
Rahul Yadav
Simone Brixius-Anderko
Emily E. Scott
Lars Olsen
Flemming Steen Jørgensen
Fredrik Björkling
author_sort Tomasz M. Wróbel
title Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
title_short Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
title_full Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
title_fullStr Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
title_full_unstemmed Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents
title_sort discovery of novel non-steroidal cytochrome p450 17a1 inhibitors as potential prostate cancer agents
publisher MDPI AG
series International Journal of Molecular Sciences
issn 1661-6596
1422-0067
publishDate 2020-07-01
description The current study presents the design, synthesis, and evaluation of novel cytochrome P450 17A1 (CYP17A1) ligands. CYP17A1 is a key enzyme in the steroidogenic pathway that produces androgens among other steroids, and it is implicated in prostate cancer. The obtained compounds are potent enzyme inhibitors (sub µM) with antiproliferative activity in prostate cancer cell lines. The binding mode of these compounds is also discussed.
topic cytochrome P450 17A1, CYP17A1
prostate cancer
enzyme inhibition
url https://www.mdpi.com/1422-0067/21/14/4868
work_keys_str_mv AT tomaszmwrobel discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT oksanarogova discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT kasperlandersen discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT rahulyadav discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT simonebrixiusanderko discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT emilyescott discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT larsolsen discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT flemmingsteenjørgensen discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
AT fredrikbjorkling discoveryofnovelnonsteroidalcytochromep45017a1inhibitorsaspotentialprostatecanceragents
_version_ 1724540707114319872